A new gene therapy has shown promise in slowing the progression of Huntington's disease by 75%, offering significant hope to patients and families. This breakthrough, described as "winning the lottery 10 times over," could potentially alter the outlook for individuals with the normally fatal condition. While regulatory and NHS approval processes are ongoing, with potential availability in early 2027, the development is seen as a monumental step forward, providing much-needed optimism where there was none.

Prepared by Olivia Bennett and reviewed by editorial team.